TherapeuticsMD
TXMD
#10102
Rank
โ‚ฌ21.09 M
Marketcap
1,82ย โ‚ฌ
Share price
-6.09%
Change (1 day)
72.90%
Change (1 year)

Market capitalization of TherapeuticsMD (TXMD)

Market cap: โ‚ฌ21.09 Million

As of February 2026 TherapeuticsMD has a market cap of โ‚ฌ21.09 Million. This makes TherapeuticsMD the world's 10102th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of TherapeuticsMD from 2003 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ21.09 M23.02%
2025โ‚ฌ17.14 M41.92%
2024โ‚ฌ12.07 M-43.88%
2023โ‚ฌ21.52 M-56.37%
2022โ‚ฌ49.33 M-63.01%
2021โ‚ฌ0.13 B-54.77%
2020โ‚ฌ0.29 B-49.66%
2019โ‚ฌ0.58 B-26.85%
2018โ‚ฌ0.80 B-26.49%
2017โ‚ฌ1.08 B1.03%
2016โ‚ฌ1.07 B-36.1%
2015โ‚ฌ1.68 B195.46%
2014โ‚ฌ0.57 B4.43%
2013โ‚ฌ0.54 B133.88%
2012โ‚ฌ0.23 B149.32%
2011โ‚ฌ93.79 M24180.19%
2010โ‚ฌ0.38 M-97.3%
2009โ‚ฌ14.32 M1211.63%
2008โ‚ฌ1.09 M205.57%
2007โ‚ฌ0.35 M-57.21%
2006โ‚ฌ0.83 M19.7%
2005โ‚ฌ0.69 M67.67%
2004โ‚ฌ0.41 M-15.96%
2003โ‚ฌ0.49 M

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of TherapeuticsMD was reported to be:

โ‚ฌ21.09 Million
by Nasdaq info icon info icon
โ‚ฌ21.09 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚ฌ126.81 B 601,205.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ332.50 B 1,576,438.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
โ‚ฌ8.79 M-58.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚ฌ20.50 B 97,124.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
โ‚ฌ6.22 M-70.48%๐Ÿ‡บ๐Ÿ‡ธ USA